Cargando…

Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study

PURPOSE: Chlorhexidine oral care is widely used in critically and non-critically ill hospitalized patients to maintain oral health. We investigated the effect of chlorhexidine oral care on mortality in a general hospitalized population. METHODS: In this single-center, retrospective, hospital-wide, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Deschepper, Mieke, Waegeman, Willem, Eeckloo, Kristof, Vogelaers, Dirk, Blot, Stijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061438/
https://www.ncbi.nlm.nih.gov/pubmed/29744564
http://dx.doi.org/10.1007/s00134-018-5171-3
_version_ 1783342225582718976
author Deschepper, Mieke
Waegeman, Willem
Eeckloo, Kristof
Vogelaers, Dirk
Blot, Stijn
author_facet Deschepper, Mieke
Waegeman, Willem
Eeckloo, Kristof
Vogelaers, Dirk
Blot, Stijn
author_sort Deschepper, Mieke
collection PubMed
description PURPOSE: Chlorhexidine oral care is widely used in critically and non-critically ill hospitalized patients to maintain oral health. We investigated the effect of chlorhexidine oral care on mortality in a general hospitalized population. METHODS: In this single-center, retrospective, hospital-wide, observational cohort study we included adult hospitalized patients (2012–2014). Mortality associated with chlorhexidine oral care was assessed by logistic regression analysis. A threshold cumulative dose of 300 mg served as a dichotomic proxy for chlorhexidine exposure. We adjusted for demographics, diagnostic category, and risk of mortality expressed in four categories (minor, moderate, major, and extreme). RESULTS: The study cohort included 82,274 patients of which 11,133 (14%) received chlorhexidine oral care. Low-level exposure to chlorhexidine oral care (≤ 300 mg) was associated with increased risk of death [odds ratio (OR) 2.61; 95% confidence interval (CI) 2.32–2.92]. This association was stronger among patients with a lower risk of death: OR 5.50 (95% CI 4.51–6.71) with minor/moderate risk, OR 2.33 (95% CI 1.96–2.78) with a major risk, and a not significant OR 1.13 (95% CI 0.90–1.41) with an extreme risk of mortality. Similar observations were made for high-level exposure (> 300 mg). No harmful effect was observed in ventilated and non-ventilated ICU patients. Increased risk of death was observed in patients who did not receive mechanical ventilation and were not admitted to ICUs. The adjusted number of patients needed to be exposed to result in one additional fatality case was 47.1 (95% CI 45.2–49.1). CONCLUSIONS: These data argue against the indiscriminate widespread use of chlorhexidine oral care in hospitalized patients, in the absence of proven benefit in specific populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-018-5171-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6061438
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-60614382018-08-09 Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study Deschepper, Mieke Waegeman, Willem Eeckloo, Kristof Vogelaers, Dirk Blot, Stijn Intensive Care Med Original PURPOSE: Chlorhexidine oral care is widely used in critically and non-critically ill hospitalized patients to maintain oral health. We investigated the effect of chlorhexidine oral care on mortality in a general hospitalized population. METHODS: In this single-center, retrospective, hospital-wide, observational cohort study we included adult hospitalized patients (2012–2014). Mortality associated with chlorhexidine oral care was assessed by logistic regression analysis. A threshold cumulative dose of 300 mg served as a dichotomic proxy for chlorhexidine exposure. We adjusted for demographics, diagnostic category, and risk of mortality expressed in four categories (minor, moderate, major, and extreme). RESULTS: The study cohort included 82,274 patients of which 11,133 (14%) received chlorhexidine oral care. Low-level exposure to chlorhexidine oral care (≤ 300 mg) was associated with increased risk of death [odds ratio (OR) 2.61; 95% confidence interval (CI) 2.32–2.92]. This association was stronger among patients with a lower risk of death: OR 5.50 (95% CI 4.51–6.71) with minor/moderate risk, OR 2.33 (95% CI 1.96–2.78) with a major risk, and a not significant OR 1.13 (95% CI 0.90–1.41) with an extreme risk of mortality. Similar observations were made for high-level exposure (> 300 mg). No harmful effect was observed in ventilated and non-ventilated ICU patients. Increased risk of death was observed in patients who did not receive mechanical ventilation and were not admitted to ICUs. The adjusted number of patients needed to be exposed to result in one additional fatality case was 47.1 (95% CI 45.2–49.1). CONCLUSIONS: These data argue against the indiscriminate widespread use of chlorhexidine oral care in hospitalized patients, in the absence of proven benefit in specific populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-018-5171-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-05-09 2018 /pmc/articles/PMC6061438/ /pubmed/29744564 http://dx.doi.org/10.1007/s00134-018-5171-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original
Deschepper, Mieke
Waegeman, Willem
Eeckloo, Kristof
Vogelaers, Dirk
Blot, Stijn
Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title_full Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title_fullStr Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title_full_unstemmed Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title_short Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
title_sort effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061438/
https://www.ncbi.nlm.nih.gov/pubmed/29744564
http://dx.doi.org/10.1007/s00134-018-5171-3
work_keys_str_mv AT descheppermieke effectsofchlorhexidinegluconateoralcareonhospitalmortalityahospitalwideobservationalcohortstudy
AT waegemanwillem effectsofchlorhexidinegluconateoralcareonhospitalmortalityahospitalwideobservationalcohortstudy
AT eecklookristof effectsofchlorhexidinegluconateoralcareonhospitalmortalityahospitalwideobservationalcohortstudy
AT vogelaersdirk effectsofchlorhexidinegluconateoralcareonhospitalmortalityahospitalwideobservationalcohortstudy
AT blotstijn effectsofchlorhexidinegluconateoralcareonhospitalmortalityahospitalwideobservationalcohortstudy